There are some possibilities for some cures for cancer, heart disease and alzheimers related to vaccines and gene therapy treatments for different aspects of the different diseases. Heart disease and alzheimers have the hope (though not the certainty) of broad spectrum treatments. Various gene therapy possibilities seem the most promising for new Heart disease treatments. Early detection with more accuracy and lower cost for various types of cancer and alzheimers hold the promise of near term improvement in survival and treatment.
Cancer
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
Jack Andraka's cancer test (which would cost about 3 cents for the disposable part of the test) via finding antigens has broad application for not just cancer but early detection of other diseases.
Andraka’s method proved to be 168 times faster compared to previous tests, not to mention being so sensitive that it is also 400 times more effective when it comes to an accurate diagnosis of pancreatic cancer. There is also optimism going around that this could be useful in testing for different kinds of cancer as well as HIV.
Lung cancer is the world’s top cancer killer, with over 40% of cases diagnosed at an advanced stage when the cancer has already spread widely beyond the lung and survival outcomes are extremely poor.
Read more »
Reposted via Next Big Future
Cancer
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
Jack Andraka's cancer test (which would cost about 3 cents for the disposable part of the test) via finding antigens has broad application for not just cancer but early detection of other diseases.
Andraka’s method proved to be 168 times faster compared to previous tests, not to mention being so sensitive that it is also 400 times more effective when it comes to an accurate diagnosis of pancreatic cancer. There is also optimism going around that this could be useful in testing for different kinds of cancer as well as HIV.
Lung cancer is the world’s top cancer killer, with over 40% of cases diagnosed at an advanced stage when the cancer has already spread widely beyond the lung and survival outcomes are extremely poor.
Read more »
Reposted via Next Big Future
No comments:
Post a Comment